Schedule 13G ownership disclosure

Scinai Immunotherapeutics Ltd.

Security class unavailable · CUSIP: 09073Q203

Event date: 2024-08-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000912282-24-000580
Form type
SC 13G/A
Filer
STONE DANIEL E.
CIK
CIK 1948744
Filed
Aug 20, 2024
Reporting period
Aug 19, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub